Education only. Not medical advice No products sold here For research & informational use
Field GuideGrowth HormoneTesamorelin
Growth Hormone

Tesamorelin

GHRH analog · Egrifta · the visceral-fat peptide

An FDA-approved GHRH analog best known for one thing the others aren’t: specifically reducing visceral (deep belly) fat, while supporting the body’s own GH.

📝 Community guide · reviewed by Carl · Suggest an edit
Carl reading the research Carl read the papers
so you don’t have to.

What it actually is

Tesamorelin is a stabilised GHRH analog that stimulates the pituitary to release growth hormone. It’s FDA-approved (Egrifta) for reducing excess visceral fat in HIV-associated lipodystrophy.

What makes it stand out in this category is the visceral-fat (VAT) evidence — the deep abdominal fat linked to metabolic risk — plus IGF-1 and cognitive benefits under study.

Carl’s one-liner: The GH peptide that actually targets belly fat — approved, and the go-to for visceral-fat reduction.

How it’s thought to work

What the research says

FDA-approved with real human trials for visceral-fat reduction — one of the better-evidenced compounds in the GH category. Off-label wellness/anti-aging use is common but less studied.

Reported protocols

These are the doses the peptide community actually reports running (Reddit & forums), alongside published research — logged for education, not as a recommendation to use.

ParameterCommonly reported range
Community dose1–2 mg (clinical dose is 2 mg)
FrequencyOnce daily, at night
RouteSubcutaneous
CycleMulti-month; VAT effects build over 12+ weeks
Community tipDose fasted before bed; paired with fat-loss peptides to target belly fat
Reality check: Approved for a specific indication; off-label use is unapproved. As a GHRH it carries the usual GH cautions (water retention, glucose, joint/carpal-tunnel symptoms at higher exposure). Reconstituted product is less stable — handle per storage guidance.

Common use cases

GoalCommunity protocol notes
Visceral (belly) fat1–2 mg nightly, 12+ wks
GH / IGF-1 supportnightly, fasted
With a fat-loss peptide (Deep Cut)+ Retatrutide

Mixing it (reconstitution)

Freeze-dried peptides must be reconstituted with bacteriostatic water before they can be measured. Carl’s calculator turns “mg in the vial + ml of water + target dose” into “units on the syringe” — and tells you how long the vial lasts.

→ Open the Reconstitution Calculator

Injection & handling

SubQ, 1–2 mg nightly, fasted before bed (carbs/insulin blunt GH). Visceral-fat effects build over 12+ weeks — a multi-month commitment. Reconstituted product is less stable; handle per storage guidance.

Stacks it appears in

Carl’s quick FAQ

Tesamorelin vs CJC-1295/Sermorelin?
Same GHRH family, but tesamorelin has the strongest visceral-fat evidence and an FDA approval — usually the pick when belly fat is the goal.
Why is it good for belly fat?
Its trials specifically measured (and reduced) visceral adipose tissue, which most GH peptides don’t document.
Is it approved?
Yes — as Egrifta, for HIV-associated lipodystrophy; other uses are off-label.
The honest summary: Tesamorelin is the GH peptide with the clearest, approved evidence for one goal — visceral fat. If deep belly fat is the target it’s the standout; for general ‘GH support’ the CJC+Ipamorelin route is cheaper and more common.
Carl
📩 The Field Notes

Liked this breakdown?

Carl sends one like it every week — plus the free Beginner’s Field Notes PDF. Plain English, zero hype, unsubscribe anytime.

Free. We’ll never sell your email. Education only — not medical advice.
RELATED

Keep reading